PetMed Express (NASDAQ: PETS) reported Q2 EPS of $0.00, $0.06 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $71 million versus the consensus estimate of $76.29 million.

For earnings history and earnings-related data on PetMed Express (PETS) click here.